Remember the WolfPack DC..We have insighter information on Radient and its restructuring...You understand..lol ioo
DC My Brother from another mother....Here are some posts from another den you understand... Just one Wolfpack's opinion you understand..WolfGang
Reply to
IMO, the deal with the lenders is changing.
by vestor_guy •Dec 22, 2011 11:21 AM
get_smart86 • Dec 22, 2011 12:04 PM
0 users liked this posts users disliked this posts 0
Reply
TNTSHAULING "You Said"
Re: IMO, the deal with the lenders is changing. 3 minutes ago
Get lost Adam!
Sentiment : Strong Buy
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
"I Say" and GUESS
That News of sales from "Down Under" will be coming out soon. Get Smart
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Radient Pharmaceuticals Files International Patents in Australia and New Zealand
TUSTIN, CA, Sep 14, 2011 (LevelStock.com News) -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has filed for patent protection for its proprietary Onko-Sure(R) cancer test in Australia and New Zealand.
"Building an intellectual property position in foreign markets protects and supports sales of our proprietary Onko-Sure(R) cancer test globally. Both Australia and New Zealand have highly developed healthcare markets where we believe Onko-Sure(R) can add value as a minimally invasive, relatively low cost cancer diagnostic," stated Radient Chairman and CEO Douglas MacLellan.
The Onko-Sure(R) test kit is a 96-well ELISA test kit sold to clinical reference labs. Labs run individual tests prescribed by doctors. Blood samples can be run, in duplicate, for 40 people, on each test kit. Onko-Sure(R) is a non-invasive cancer blood test that has been shown, in a large body of published clinical research, to be effective in the detection of 19 different cancers.
**************************************************************
Reply to
IMO, the deal with the lenders is changing.
by vestor_guy •Dec 22, 2011 11:21 AM
get_smart86 • Dec 22, 2011 7:49 PM
1 users liked this posts users disliked this posts 0
Reply
DUCKSOUP125 "You Said"
Re: IMO, the deal with the lenders is changing. 22-Dec-11 05:01 pm
"Down Under sales. Interesting"
Sentiment : Strong Buy
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++=
"I Say"
The patents should be in place soon or like Vestor, I am just Guessing...
Patent rights are typically granted on a country-by country
basis, and each country has its own rules
for determining what is patentable, which may differ
significantly from the U.S. rules.
Most of the world’s industrialized countries, including,
for example, Australia, Canada, China, Germany, India,
and Japan, are parties to an international treaty known
as the Paris Convention. The Paris Convention gives
an applicant one year to file a corresponding patent
application in a member country and still obtain an
original U.S. priority date.
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
The terms filing date and priority date are often used interchangeably, but they are not the same. The filing date is the date when a patent application is first filed at a patent office. The priority date, sometimes called the "effective filing date", is the date used to establish the novelty and/or obviousness of a particular invention relative to other art.
The priority date may be earlier than the actual filing date of an application. If an application claims priority to an earlier parent application, then its priority date may be the same as the parent.
************************************************************
Reply to
SRL Diagnostics Expansion
by ravi_ghandi2001 •Jun 12, 2013 11:45 AM
ravi_ghandi2001 • Jun 12, 2013 12:47 PM
0 users liked this posts users disliked this posts 25
Reply
Very good post brother ravi. That is why SRL is still the major player of Onko-Sure and merger. "Down Under".We can share a .vegemite sandwich
